Shamburg News · 8-K filed Nov 6, 2026, 2:15 PM EST
Protagenic Therapeutics Issues $250,000 Promissory Note to Patness LLC
PTIX · Protagenic Therapeutics, Inc.\new
- Material agreement
- Financing
- Materiality: medium
On November 4, 2026, Protagenic Therapeutics, Inc. issued a promissory note to Patness LLC for a principal sum of $250,000 bearing simple interest at 1.0% per annum. The note is due on the earliest of a equity raise of at least $1,000,000 in gross cash proceeds or 180 days from issuance, and interest is forgiven if repaid within 365 days. The note was issued under the Section 4(a)(2) private placement exemption and is filed as Exhibit 10.1.
Source: SEC EDGAR, Form 8-K, Items 1.01, 2.03, 9.01, accession 0001493152-26-050420.
Written from the filing by Shamburg Markets. Figures are as reported by the company.